The Senate Health, Education, Labor and Pensions Committee today held a hearing on President’s Trump nomination of Stephen Hahn, M.D., to lead the Food and Drug Administration as commissioner. Hahn currently serves as chief medical executive and professor of radiation oncology at The University of Texas MD Anderson Cancer Center in Houston. He previously chaired the Department of Radiation Oncology at the University of Pennsylvania and before that was a senior investigator at the National Cancer Institute.
 
Commenting on the nomination Nov. 1, AHA President and CEO Rick Pollack said Hahn’s “more than 20 years of experience on the front lines of delivering patient care, overseeing clinical research and operations, and quality and safety initiatives makes him a uniquely qualified nominee to lead the FDA.”
 
Scott Gottlieb, M.D., resigned as commissioner this spring. Adm. Brett Giroir, M.D., is currently serving as acting FDA commissioner. The committee will vote on Hahn’s nomination Dec. 3.

Related News Articles

Headline
The Senate Health, Education, Labor and Pensions Committee today voted 18-5 to approve President’s Trump nomination of Stephen Hahn, M.D., to lead the Food and…
Headline
Thomas Engels was promoted this month to administrator of the Health Resources and Services Administration after serving as acting administrator since August.
Headline
President Trump today announced his intention to nominate Stephen Hahn, M.D., to lead the Food and Drug Administration.
Headline
President Trump yesterday nominated Sarah Arbes to be assistant secretary for legislation at the Department of Health and Human Services.
Headline
John O’Brien will soon depart his position as senior advisor for drug pricing reform.
Headline
President Trump intends to nominate Adam Boehler — senior advisor to the Health and Human Services Secretary, Centers for Medicare…